Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Recent Posts
Approval from Korean regulator to initiate Phase 2 accent pancreatic cancer trial in Korea
Approval from Korean regulator to initiate Phase 2 accent pancreatic cancer trial in Korea
AUSBIZ | Interview with Dr Chris Burns
Phase 1B of ACCENT Trial in Pancreatic Cancer Complete
VIDEO | The Market Herald
Archives
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
Categories
Company News
Media
Uncategorized
Videos
November 21st, 2023
AUSBIZ | Interview with Dr Chris Burns
Read More
May 22nd, 2023
PROACTIVE INTERVIEW | Dr Chris Burns discusses Amplia's collaboration with CSIRO
Read More
April 19th, 2023
First Patient Recruited to Cohort 3 of ACCENT Trial in Pancreatic Cancer
Read More
February 6th, 2023
Channel 9 News | 3 February 2023
Read More
February 6th, 2023
The Courier Mail | New hope for advanced pancreatic cancer patients in clinical trials
Read More
February 6th, 2023
ABC Media Coverage | Pancreatic cancer clinical trial opens in Queensland, offering hope to patients
Read More
January 30th, 2023
PROACTIVE INTERVIEW | Dr Chris Burns
Read More
September 28th, 2022
Stockhead Investor Guide
Read More
August 18th, 2022
Channel 9 | Clinical Trial Recruitment
Read More
August 18th, 2022
The Australian | Drug to tear down tumour defences
Read More
August 18th, 2022
The Front Podcast | 18 August 2022
Read More
May 9th, 2022
ABC News | Bioshares
Read More
April 5th, 2022
New investment in pancreatic cancer research
Read More
February 11th, 2022
WOMEN IN SCIENCE | Rhiannon Jones, Director, Operations
Read More
February 1st, 2022
VIDEO | PROACTIVE Amplia Therapeutics readies for phase two clinical trials and "watershed year" for AMP945
Read More
November 30th, 2021
VIDEO | SMALL CAPS Amplia Therapeutics makes headway in anti-cancer clinical trial
Read More
November 18th, 2021
VIDEO | PROACTIVE Amplia Therapeutics details summary results from its phase 1 clinical trial of AMP945
Read More
November 10th, 2021
VIDEO | AUSBIZ Amplia's $12M plan; what's next for the Aussie medtech
Read More
October 21st, 2021
Switzer Daily | Therapeutics company primed for growth
Read More
September 30th, 2021
Amplia Therapeutics welcomes Garvan paper highlighting benefits of FAK inhibition in pancreatic cancer models
Read More
1
2
